Candel Therapeutics Inc (CADL)
11.56
-1.14
(-8.98%)
USD |
NASDAQ |
May 17, 16:00
11.51
-0.05
(-0.43%)
After-Hours: 20:00
Candel Therapeutics Price to Book Value: 57.21 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 57.21 |
| May 16, 2024 | 63.18 |
| May 15, 2024 | 69.65 |
| May 14, 2024 | 53.23 |
| May 13, 2024 | 50.74 |
| May 10, 2024 | 46.37 |
| May 09, 2024 | 49.60 |
| May 08, 2024 | 53.88 |
| May 07, 2024 | 47.71 |
| May 06, 2024 | 44.03 |
| May 03, 2024 | 44.27 |
| May 02, 2024 | 41.38 |
| May 01, 2024 | 39.17 |
| April 30, 2024 | 34.60 |
| April 29, 2024 | 31.46 |
| April 26, 2024 | 31.36 |
| April 25, 2024 | 31.56 |
| April 24, 2024 | 29.70 |
| April 23, 2024 | 29.01 |
| April 22, 2024 | 27.19 |
| April 19, 2024 | 25.38 |
| April 18, 2024 | 26.80 |
| April 17, 2024 | 26.70 |
| April 16, 2024 | 28.91 |
| April 15, 2024 | 28.57 |
| Date | Value |
|---|---|
| April 12, 2024 | 32.69 |
| April 11, 2024 | 35.73 |
| April 10, 2024 | 25.03 |
| April 09, 2024 | 24.98 |
| April 08, 2024 | 31.56 |
| April 05, 2024 | 32.59 |
| April 04, 2024 | 31.41 |
| April 03, 2024 | 8.246 |
| April 02, 2024 | 8.295 |
| April 01, 2024 | 8.590 |
| March 28, 2024 | 3.638 |
| March 27, 2024 | 3.546 |
| March 26, 2024 | 3.431 |
| March 25, 2024 | 3.500 |
| March 22, 2024 | 3.454 |
| March 21, 2024 | 3.339 |
| March 20, 2024 | 3.424 |
| March 19, 2024 | 3.424 |
| March 18, 2024 | 3.196 |
| March 15, 2024 | 3.424 |
| March 14, 2024 | 3.561 |
| March 13, 2024 | 3.584 |
| March 12, 2024 | 3.675 |
| March 11, 2024 | 3.835 |
| March 08, 2024 | 3.584 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8203
Minimum
Oct 20 2022
69.65
Maximum
May 15 2024
3.708
Average
1.581
Median
Price to Book Value Benchmarks
| Allurion Technologies Inc | -- |
| AngioDynamics Inc | 1.106 |
| Eliem Therapeutics Inc | 2.256 |
| Macrogenics Inc | 2.576 |
| GlycoMimetics Inc | 0.6676 |
Price to Book Value Related Metrics
| PS Ratio | 2689.95 |
| Price | 11.56 |
| Earnings Yield | -11.13% |
| Market Cap | 342.06M |